| Michael J Babb, MD | |
|
318 Maxwell Rd, Alpharetta, GA 30009-2063 | |
| (770) 274-0480 | |
| (770) 740-0896 |
| Full Name | Michael J Babb |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 318 Maxwell Rd, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144298399 | NPI | - | NPPES |
| 100254140B | Medicaid | OK | |
| 731251724001 | Other | OK | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 14271 (Oklahoma) | Secondary |
| 208M00000X | Hospitalist | 47096 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Williamson Medical Center | Franklin, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Williamson Hospitalist Program | 0042553158 | 38 |
News Archive
A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
Republican staff on the Energy and Commerce Committee are considering a proposal to address the problem of looming cuts to Medicare physician payments by implementing a pay-for-performance system, according to lobbying sources.
Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Women who had a caesarean section in a previous pregnancy are much more likely to have a safer vaginal birth if their antenatal care is led by a midwife, according to a new study from The University of Manchester.
› Verified 1 days ago
| Entity Name | Cogent Healthcare Of Tennessee, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952654246 PECOS PAC ID: 8628221165 Enrollment ID: O20130110000564 |
News Archive
A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
Republican staff on the Energy and Commerce Committee are considering a proposal to address the problem of looming cuts to Medicare physician payments by implementing a pay-for-performance system, according to lobbying sources.
Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Women who had a caesarean section in a previous pregnancy are much more likely to have a safer vaginal birth if their antenatal care is led by a midwife, according to a new study from The University of Manchester.
› Verified 1 days ago
| Entity Name | Williamson Hospitalist Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871057158 PECOS PAC ID: 0042553158 Enrollment ID: O20190513001520 |
News Archive
A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
Republican staff on the Energy and Commerce Committee are considering a proposal to address the problem of looming cuts to Medicare physician payments by implementing a pay-for-performance system, according to lobbying sources.
Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Women who had a caesarean section in a previous pregnancy are much more likely to have a safer vaginal birth if their antenatal care is led by a midwife, according to a new study from The University of Manchester.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Babb, MD 318 Maxwell Rd, Alpharetta, GA 30009-2063 Ph: (770) 274-0480 | Michael J Babb, MD 318 Maxwell Rd, Alpharetta, GA 30009-2063 Ph: (770) 274-0480 |
News Archive
A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
Republican staff on the Energy and Commerce Committee are considering a proposal to address the problem of looming cuts to Medicare physician payments by implementing a pay-for-performance system, according to lobbying sources.
Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures.
Women who had a caesarean section in a previous pregnancy are much more likely to have a safer vaginal birth if their antenatal care is led by a midwife, according to a new study from The University of Manchester.
› Verified 1 days ago
Dr. Hasan Z Saiyed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1981 Seven Seas Ct, Alpharetta, GA 30005 Phone: 404-444-3132 |